Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RINITYN TABLET 10 mg - HSA Drug Approval Details

Approvals/HSA/RINITYN TABLET 10 mg

Approved

THERAPEUTIC

RINITYN TABLET 10 mg

HOVID BHDHOVID Bhd.🇸🇬 Health Sciences Authority

Approval Date: Sep 12, 2002
Approval ID: f07c596f8dc86b83
Company: HOVID BHDHOVID Bhd.
Type: Therapeutic

Approval Details

Approval Id: f07c596f8dc86b83
Drug Name: RINITYN TABLET 10 mg
Product Name: RINITYN TABLET 10 mg
Approval Number: SIN12067P
Approval Date: 2002-09-12
Registrant: GOLDPLUS UNIVERSAL PTE LTD
Licence Holder: GOLDPLUS UNIVERSAL PTE LTD
Drug Type: Therapeutic
Forensic Classification: Pharmacy Only
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: R06AX13
Atc Item Name: loratadine
Pharma Manufacturer Name: GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path: /organization/goldplus-universal-pte-ltd

Active Ingredients

LORATADINE

10.00 mg

LORATADINE

10 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Sep 12, 2002

Approval ID

f07c596f8dc86b83

Type

Therapeutic

Back to HSA Approvals